Trial Profile
Effects of prasugrel, ticagrelor, and clopidogrel on endothelial function and platelet reactivity in patients with stable coronary artery disease one month after percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2014
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 23 Apr 2014 New trial record
- 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.